1Mohan V, Deepa M, Farooq S, et al. Prevalence, awareness and control of hypertension in Chennai-The Chennai Urban Rural Epi- demiology Study ( CURES-52 ) [ J ]. J Assoc Physicians India, 2007,55:326-332.
2Bender SB, McGraw AP, Jaffe IZ, et al. Mineralocorticoid recep- tor-mediated vascular insulin resistance : an early contributor to di-abetes-related vascular disease? [ J ]. Diabetes, 2013,62 (2) : 313-319.
3Luitse M J, Biessels GJ, Rutten GE, et al. Diabetes, hyperglycae- mia, and acuteischaemic stroke [ J ]. Lancet Neurol, 2012,11 (3) : 261-271.
4Hewitt J, Castilla Guerra L, Fernandez-Moreno Mdel C, et al. Si- erra C; Diabetes and stroke prevention: a review[ J]. Stroke Res Treat, 2012,2012:673187.
5Alavantic C, Djuric T. Risk factors of atherosclerosis : A review of genetic epidemiology data frbm a Serbian population, Exp [ J ]. Clin Cardiol, 2006,11 (2) :78-82.
6Gongora-Rivera F, Labreuche J, Jaramillo A, et al. Autopsy prev- alence of coronary atheroselerosis in patients with fatal stroke [ J ]. Stroke, 2007,38 (4) : 1203-1210.
7Iwata I-I, Aikawa M. Liver-artery interactions via the plasminogen- CD36 axis in macrophage foam cell formation: new evidence for the role of remote organ erosstalk in atherosclerosis [ J ]. Circula- tion, 2013,127(11) :1173-1176.
8Sun Y, Scavini M, Orlando RA, et al. Increased CD36 expression signalsmonocyte activation among patients with type 2 diabetes [J]. Diab Care, 2010,33(9) :2065-2067.
9Greenwalt DE, Lipsky RH, Ockenhouse CF, et al. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine [ J ]. Blood, 1992, 80 (5) :1105-1115.
10Oquendo P, Hundt E, Lawler J, et al. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythroeytes [J]. Cell, 1989,58(1) :95-101.
